Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Capital One
COF
|
+$445M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$405M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$387M |
| 4 |
Johnson & Johnson
JNJ
|
+$256M |
| 5 |
Procter & Gamble
PG
|
+$170M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$536M |
| 2 |
NVIDIA
NVDA
|
+$471M |
| 3 |
X
US Steel
X
|
+$421M |
| 4 |
JPMorgan Chase
JPM
|
+$237M |
| 5 |
Deere & Co
DE
|
+$235M |
Sector Composition
| 1 | Technology | 20.97% |
| 2 | Financials | 18.52% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Healthcare | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Nautilus Biotechnolgy
NAUT
$88.5M
| $399K | ﹤0.01% |
550,740
-109,178
| -17% | -$79.1K |
|
3027
Tyra Biosciences
TYRA
$674M
| $399K | ﹤0.01% |
41,681
+6,969
| +20% | +$66.7K |
|
|
ACCS
3028
ACCESS Newswire Inc.
ACCS
$42.2M
| $398K | ﹤0.01% |
32,333
+1,103
| +4% | +$13.6K |
|
3029
IF Bancorp
IROQ
$82.1M
| $397K | ﹤0.01% |
16,115
+942
| +6% | +$23.2K |
|
3030
Sundial Growers
SNDL
$615M
| $397K | ﹤0.01% |
328,065
-11,689
| -3% | -$14.1K |
|
3031
Broadwind
BWEN
$47.2M
| $391K | ﹤0.01% |
215,869
| – | – |
|
3032
Varonis Systems
VRNS
$6.45B
| $390K | ﹤0.01% |
7,685
-142,489
| -95% | -$7.23M |
|
3033
Zentalis Pharmaceuticals
ZNTL
$118M
| $390K | ﹤0.01% |
335,966
-111,434
| -25% | -$129K |
|
|
TECX
3034
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $387K | ﹤0.01% |
19,498
-12,663
| -39% | -$252K |
|
|
MODV
3035
DELISTED
ModivCare
MODV
| $387K | ﹤0.01% |
123,916
-114,533
| -48% | -$358K |
|
3036
Flexible Solutions
FSI
$120M
| $382K | ﹤0.01% |
78,781
+7,800
| +11% | +$37.8K |
|
3037
Grupo SIMEC
SIM
$3.84B
| $381K | ﹤0.01% |
14,111
+53
| +0.4% | +$1.43K |
|
3038
GoHealth
GOCO
$76.9M
| $379K | ﹤0.01% |
68,228
+40,657
| +147% | +$226K |
|
3039
Oramed Pharmaceuticals
ORMP
$94.3M
| $376K | ﹤0.01% |
166,899
+25,818
| +18% | +$58.1K |
|
3040
Immersion
IMMR
$231M
| $375K | ﹤0.01% |
47,579
-12,762
| -21% | -$101K |
|
3041
Nektar Therapeutics
NKTR
$843M
| $372K | ﹤0.01% |
14,380
-10,530
| -42% | -$272K |
|
3042
Eledon Pharmaceuticals
ELDN
$154M
| $370K | ﹤0.01% |
136,456
+20,281
| +17% | +$54.9K |
|
3043
Trinseo
TSE
$86.3M
| $369K | ﹤0.01% |
118,126
+14,153
| +14% | +$44.3K |
|
3044
Gray Media, Inc. Class A
GTN.A
$1.02B
| $367K | ﹤0.01% |
33,800
| – | – |
|
3045
Pliant Therapeutics
PLRX
$106M
| $367K | ﹤0.01% |
315,887
-195,831
| -38% | -$227K |
|
3046
Bioceres Crop Solutions
BIOX
$161M
| $365K | ﹤0.01% |
81,671
| – | – |
|
3047
Comstock Holding Companies
CHCI
$174M
| $364K | ﹤0.01% |
36,071
+1,005
| +3% | +$10.1K |
|
3048
CuriosityStream
CURI
$265M
| $354K | ﹤0.01% |
63,130
+15,067
| +31% | +$84.5K |
|
3049
Urban One Class D
UONEK
$39.9M
| $354K | ﹤0.01% |
560,535
-132,238
| -19% | -$83.4K |
|
3050
Envela
ELA
$198M
| $350K | ﹤0.01% |
57,264
| – | – |
|